StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Tibet Cheezheng Tibetan Medicine Co., Ltd.
Shenzhen Stock Exchange:002287.SZ
Sector
Location
Market Cap
USD 1.85 B
Share Price
USD 3.46
Avg Daily Volume
3,301,088
Change (1 day)
-0.36%
Change (1 year)
36.14%
Change (YTD)
18.10%
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2024: 14.33%
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) is 14.33% for the year ending December 31, 2024, a -8.29% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023 was 15.62%, a 10.29% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 14.16%, a -37.30% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 22.59%, a 46.41% change year over year.
-
Tibet Cheezheng Tibetan Medicine Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 15.43%, a -4.88% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
Ascendis Pharma A/S
USD 168.31
ASND
-1.83
-1.08%
Regencell Bioscience Holdings Limited
USD 15.18
RGC
+0.39
2.64%
Laurus Labs Limited
USD 9.74
LAURUSLABS.NS
+0.06
0.66%
Ipca Laboratories Limited
USD 18.13
IPCALAB.NS
+0.31
1.73%
ADMA Biologics, Inc.
USD 17.31
ADMA
+0.11
0.64%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.27
002603.SZ
+0.08
3.46%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.83
600566.SS
-0.03
-0.72%
Pfizer Limited
USD 62.77
PFIZER.NS
+1.61
2.64%
BGI Genomics Co., Ltd.
USD 7.39
300676.SZ
+0.23
3.16%
Eris Lifesciences Limited
USD 20.78
ERIS.NS
+0.13
0.64%
Liaoning Cheng Da Co., Ltd.
USD 1.71
600739.SS
+0.04
2.50%
Vimian Group AB (publ)
USD 3.77
VIMIAN.ST
-0.16
-4.00%
Hybio Pharmaceutical Co., Ltd.
USD 2.61
300199.SZ
+0.01
0.56%
Harmony Biosciences Holdings, Inc.
USD 36.71
HRMY
-0.51
-1.37%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.21
002020.SZ
+0.04
1.88%
NovoCure Limited
USD 12.54
NVCR
-3.97
-24.05%
Arcutis Biotherapeutics, Inc.
USD 15.02
ARQT
+0.11
0.74%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
Ascendis Pharma A/S
USD 168.31
ASND
-1.83
-1.08%
Regencell Bioscience Holdings Limited
USD 15.18
RGC
+0.39
2.64%
Laurus Labs Limited
USD 9.74
LAURUSLABS.NS
+0.06
0.66%
Ipca Laboratories Limited
USD 18.13
IPCALAB.NS
+0.31
1.73%
ADMA Biologics, Inc.
USD 17.31
ADMA
+0.11
0.64%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.27
002603.SZ
+0.08
3.46%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.83
600566.SS
-0.03
-0.72%
Pfizer Limited
USD 62.77
PFIZER.NS
+1.61
2.64%
BGI Genomics Co., Ltd.
USD 7.39
300676.SZ
+0.23
3.16%
Eris Lifesciences Limited
USD 20.78
ERIS.NS
+0.13
0.64%
Liaoning Cheng Da Co., Ltd.
USD 1.71
600739.SS
+0.04
2.50%
Vimian Group AB (publ)
USD 3.77
VIMIAN.ST
-0.16
-4.00%
Hybio Pharmaceutical Co., Ltd.
USD 2.61
300199.SZ
+0.01
0.56%
Harmony Biosciences Holdings, Inc.
USD 36.71
HRMY
-0.51
-1.37%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.21
002020.SZ
+0.04
1.88%
NovoCure Limited
USD 12.54
NVCR
-3.97
-24.05%
Arcutis Biotherapeutics, Inc.
USD 15.02
ARQT
+0.11
0.74%